+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Peritoneal Dialysis Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 183 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968557
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior healthcare leaders are actively assessing the peritoneal dialysis market as it becomes increasingly pivotal in modern renal care strategy. The sector is advancing on the strength of patient-centric innovation, regulatory change, and evolving care delivery expectations—making timely market intelligence indispensable for strategic planning.

Market Snapshot: Peritoneal Dialysis Market Growth and Dynamics

The peritoneal dialysis market is progressing rapidly, rising from USD 9.86 billion in 2024 to USD 10.43 billion in 2025, and projected to achieve USD 15.83 billion by 2032. This sustained momentum underlines the market’s fundamental role in kidney care, benefiting from broadened clinical access, improved standards, and sustained investment in patient- and provider-focused solutions. Expanded adoption of home-based modalities and inventive product development continue to drive segment growth alongside structural advancements across the value chain. Providers and technology developers are prioritizing improvements in the overall experience, while regulatory frameworks and reimbursement policies further support widespread uptake.

Scope & Segmentation: Strategic View for Senior Decision-Makers

  • Product Types: Includes accessories such as PD solution bags, drainage bags, catheter kits, and transfer sets, alongside peritoneal dialysis machines (automated cyclers, continuous ambulatory devices) and a full spectrum of peritoneal solutions, covering biocompatible, glucose-based, and low-glucose formulas.
  • Therapeutic Areas: Designed to address both acute kidney injury and chronic kidney disease, while also targeting complex populations such as those with congestive heart failure who require tailored renal therapies and nuanced clinical oversight.
  • Application Spectrum: Applicable to patients with diabetic nephropathy, glomerulonephritis, lupus nephritis, and polycystic kidney disease, supporting a broad clinical footprint across renal pathology management.
  • End Users: Serves dialysis centers, hospital systems, and home care settings, enabling adaptable delivery models that meet expanding demand for patient-driven and centralized solutions alike.
  • Regional Analysis: Covers Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East, and Africa (including the United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, UAE, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan). Each region exhibits varied dynamics shaped by healthcare infrastructure, clinical adoption, and reimbursement schemes.
  • Key Technologies: Features advancements such as automated peritoneal dialysis cyclers, integration of telehealth-enabled remote monitoring platforms, biocompatible dialysis solutions, and modular equipment designs that streamline efficiency and accommodate localization.
  • Leading Companies: Major industry participants include Advin Health Care, Angiplast Pvt. Ltd., B. Braun Medical Ltd, Baxter International, Becton, Dickinson and Company, Cook Group, Diaverum AB by M42, Fresenius Medical Care, Huaren Pharmaceutical, JDmeditech, JMS, Medionics International, Mitra Industries, Mozarc Medical, Opterion Health, PFM Medical, Renax Biomedical Technology, Renfrew Group International, Romsons Prime Private Limited, Terumo Corporation, Toray Industries, and Vivance.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Peritoneal dialysis adoption is tightly linked to the shift toward patient-centered, home-based renal care, allowing providers to improve both patient adherence and overall satisfaction.
  • Advancement in automation and remote monitoring delivers greater personalization and safety, supporting risk reduction and sustained improvements in clinical outcomes.
  • Decentralized healthcare infrastructures offer pathways to operational cost efficiencies and reduced dependence on traditional hospital resources, responding to changing industry workflows.
  • Strategic collaborations between technology and pharmaceutical firms are emerging as powerful levers for innovation acceleration and smoother regulatory navigation.
  • Regional disparities in infrastructure, policy, and reimbursement require market entrants to design strategies attuned to local conditions, especially in Asia-Pacific’s dynamic landscape.
  • Industry leaders are mitigating supply chain risk through increased use of local manufacturing, adaptive procurement, and digitalized supply management practices, safeguarding long-term continuity.

Tariff Impact: Navigating 2025 Equipment Tariffs

In the United States, upcoming 2025 tariff reforms are reshaping the cost landscape for peritoneal dialysis cyclers, delivery equipment, and consumables. Stakeholders are adapting through revised procurement practices, fostering new domestic alliances, and prioritizing product standardization to maintain resilient supply chains. Measures such as value-based contracting are addressing affordability pressures and aligning with evolving reimbursement models, positioning organizations to sustain patient access amid policy change.

Methodology & Data Sources

This analysis integrates direct input from nephrology experts, insights from dialysis center leaders, and technical viewpoints from biomedical professionals. Supplementary data sources include regulatory documents, clinical journals, patent records, and industry reports, with findings further validated in stakeholder workshops and via financial disclosure reviews.

Peritoneal Dialysis Market: Why This Report Matters

  • Presents executive decision-makers with actionable segmentation and recommendations across products, technologies, and evolving patient trends for superior strategic alignment.
  • Supplies guidance for overcoming sector challenges—from patient engagement and care modernization to regulatory complexity and infrastructure innovation.
  • Provides a benchmarking platform for competitive analysis and forward-looking assessment of market opportunities, risks, and operational best practices.

Conclusion

The peritoneal dialysis market is being reshaped by technology innovation and decentralized care models. Senior leaders can leverage these insights to confidently direct transformation and adapt kidney care strategies for sustained impact.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Rising adoption of remote patient monitoring and telehealth platforms to improve peritoneal dialysis adherence and outcomes
5.2. Increasing shift toward home-based automated peritoneal dialysis systems with integrated AI-driven prescription adjustments
5.3. Development of biocompatible peritoneal dialysis solutions with neutral pH and reduced glucose degradation products to enhance patient comfort
5.4. Growing investment in novel catheter designs and implantable port systems to minimize infection rates and improve patient experience
5.5. Advances in wearable peritoneal dialysis devices and continuous flow technologies aiming to reduce treatment burden and enhance quality of life
5.6. Expansion of peritoneal dialysis programs in emerging markets driven by cost advantages and localized training initiatives to address chronic kidney disease burden
5.7. Integration of data analytics and digital health tools for personalized peritoneal dialysis prescription optimization and risk stratification models
5.8. Implementation of patient education and support platforms leveraging gamification to boost adherence and self-care in peritoneal dialysis therapy
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Peritoneal Dialysis Market, by Product Type
8.1. Accessories
8.1.1. Bags for PD solutions
8.1.2. Drainage bags
8.1.3. Peritoneal Dialysis Catheter Kit
8.1.4. Transfer sets
8.2. PD Machines
8.2.1. Automated Peritoneal Dialysis Cycler
8.2.2. Continuous Ambulatory Peritoneal Dialysis
8.3. Peritoneal Solution
8.3.1. Biocompatible solutions
8.3.2. Glucose-based solutions
8.3.3. Low-glucose solutions
9. Peritoneal Dialysis Market, by Therapeutic Area
9.1. Acute Kidney Injury
9.2. Chronic Kidney Disease
9.3. Congestive Heart Failure
10. Peritoneal Dialysis Market, by Application
10.1. Diabetic Nephropathy
10.2. Glomerulonephritis
10.3. Lupus Nephritis
10.4. Polycystic Kidney Disease
11. Peritoneal Dialysis Market, by End User
11.1. Dialysis Centers
11.2. Home Healthcare
11.3. Hospitals
12. Peritoneal Dialysis Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Peritoneal Dialysis Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Peritoneal Dialysis Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Advin Health Care
15.3.2. Angiplast Pvt. Ltd.
15.3.3. B. Braun Medical Ltd
15.3.4. Baxter International, Inc.
15.3.5. Becton, Dickinson and Company
15.3.6. Cook Group Incorporated
15.3.7. Diaverum AB by M42
15.3.8. Fresenius Medical Care AG
15.3.9. Huaren Pharmaceutical Co., Ltd.
15.3.10. JDmeditech
15.3.11. JMS Co., Ltd.
15.3.12. Medionics International Inc.
15.3.13. Mitra Industries
15.3.14. Mozarc Medical
15.3.15. Opterion Health AG
15.3.16. PFM Medical, Inc.
15.3.17. Renax Biomedical Technology Co., Ltd.
15.3.18. Renfrew Group International
15.3.19. Romsons Prime Private limited
15.3.20. Terumo Corporation
15.3.21. Toray Industries, Inc.
15.3.22. Vivance
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Peritoneal Dialysis market report include:
  • Advin Health Care
  • Angiplast Pvt. Ltd.
  • B. Braun Medical Ltd
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Cook Group Incorporated
  • Diaverum AB by M42
  • Fresenius Medical Care AG
  • Huaren Pharmaceutical Co., Ltd.
  • JDmeditech
  • JMS Co., Ltd.
  • Medionics International Inc.
  • Mitra Industries
  • Mozarc Medical
  • Opterion Health AG
  • PFM Medical, Inc.
  • Renax Biomedical Technology Co., Ltd.
  • Renfrew Group International
  • Romsons Prime Private limited
  • Terumo Corporation
  • Toray Industries, Inc.
  • Vivance

Table Information